Bank of New York Mellon Corp - CLOVIS ONCOLOGY INC ownership

CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 158 filers reported holding CLOVIS ONCOLOGY INC in Q4 2021. The put-call ratio across all filers is 1.47 and the average weighting 0.0%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of CLOVIS ONCOLOGY INC
ValueSharesWeighting
Q3 2022$117,000
-7.9%
97,995
+39.0%
0.00%
Q2 2022$127,000
-83.1%
70,518
-81.0%
0.00%
Q1 2022$750,000
-24.9%
371,296
+0.7%
0.00%
Q4 2021$999,000
-40.6%
368,661
-2.3%
0.00%
Q3 2021$1,683,000
-3.4%
377,296
+25.7%
0.00%
Q2 2021$1,742,000
-27.3%
300,273
-12.0%
0.00%
Q1 2021$2,395,000
+17.8%
341,256
-19.4%
0.00%
Q4 2020$2,033,000
-5.7%
423,537
+14.6%
0.00%
-100.0%
Q3 2020$2,155,000
-6.4%
369,653
+8.3%
0.00%0.0%
Q2 2020$2,303,000
+27.9%
341,321
+20.5%
0.00%0.0%
Q1 2020$1,800,000
-12.9%
283,142
+42.9%
0.00%0.0%
Q4 2019$2,066,000
+163.9%
198,196
-0.5%
0.00%
Q3 2019$783,000
-76.6%
199,132
-11.5%
0.00%
-100.0%
Q2 2019$3,346,000
-47.0%
225,013
-11.5%
0.00%
-50.0%
Q1 2019$6,311,000
+44.8%
254,260
+4.8%
0.00%
+100.0%
Q4 2018$4,359,000
-35.6%
242,702
+5.3%
0.00%
-50.0%
Q3 2018$6,770,000
-38.8%
230,497
-5.3%
0.00%
-33.3%
Q2 2018$11,069,000
-17.9%
243,461
-4.7%
0.00%
-25.0%
Q1 2018$13,488,000
-21.2%
255,459
+1.5%
0.00%
-20.0%
Q4 2017$17,122,000
-24.5%
251,802
-8.5%
0.01%
-16.7%
Q3 2017$22,688,000
-67.0%
275,326
-62.5%
0.01%
-68.4%
Q2 2017$68,709,000
+340.8%
733,846
+199.7%
0.02%
+375.0%
Q1 2017$15,588,000
+101.4%
244,821
+40.5%
0.00%
+100.0%
Q4 2016$7,741,000
+23.4%
174,282
+0.1%
0.00%0.0%
Q3 2016$6,274,000
+177.6%
174,027
+5.6%
0.00%
+100.0%
Q2 2016$2,260,000
-22.8%
164,735
+8.1%
0.00%0.0%
Q1 2016$2,927,000
-47.1%
152,430
-3.6%
0.00%
-50.0%
Q4 2015$5,536,000
-67.6%
158,156
-15.0%
0.00%
-60.0%
Q3 2015$17,109,000
+5.4%
186,051
+0.7%
0.01%
+25.0%
Q2 2015$16,236,000
+36.1%
184,747
+14.9%
0.00%
+33.3%
Q1 2015$11,932,000
+41.0%
160,738
+6.4%
0.00%
+50.0%
Q4 2014$8,464,000
+35.1%
151,135
+9.4%
0.00%0.0%
Q3 2014$6,264,000
-43.1%
138,097
-48.1%
0.00%
+100.0%
Q2 2014$11,012,000
+34.7%
265,892
+125.4%
0.00%
-50.0%
Q1 2014$8,173,000
+31.3%
117,983
+14.2%
0.00%0.0%
Q4 2013$6,226,000
-36.6%
103,303
-36.1%
0.00%
+100.0%
Q3 2013$9,824,000
+77.0%
161,592
+95.0%
0.00%
-50.0%
Q2 2013$5,551,00082,8640.00%
Other shareholders
CLOVIS ONCOLOGY INC shareholders Q4 2021
NameSharesValueWeighting ↓
Coppell Advisory Solutions LLC 229$11,0080.00%
View complete list of CLOVIS ONCOLOGY INC shareholders